TY - JOUR
T1 - Subchronic toxicity studies of the aqueous extract of Aristolochiae fructus in sprague-dawley rats
AU - Hwang, Myung Sil
AU - Park, Mi Sun
AU - Moon, Ji Young
AU - Lee, Ji Sun
AU - Yum, Young Na
AU - Yoon, Eungkyung
AU - Lee, Hyomin
AU - Nam, Ki Taek
AU - Lee, Byung Mu
AU - Kim, Seung Hee
AU - Yang, Ki Hwa
PY - 2006/6/1
Y1 - 2006/6/1
N2 - The subchronic toxicity of Aristolochiae fructus containing aristolochic acids (AAs), a natural component in the Aristolochiaceae family, was investigated. The A. fructus was daily administered by gavage to male and female rats for 90 d at dose levels of 21.35, 213.5, and 2135 mg/kg (equivalent to 0.05, 0.5, and 5 mg/kg as AAs, respectively). During the test period, clinical signs, mortality, body weights, food and water consumption, hematology, serum biochemistry, organ weights, and histopathology were examined. Significant decreases in body weight gain were noted in the high-dose group receiving both the aqueous extract of A. fructus and AAs. Decreases in food consumption were noted beginning at 50 d and did not recover in the highdose group of aqueous extract of A. fructus and AAs. Irrespective of dose, water consumption was not affected. There was no mortality or adverse clinical signs, hematology, or serum biochemistry in the treatment groups versus control. Nephrotoxicity and hyperplasia of epithelial cells in the forestomach were observed in rats receiving the highest dose of aqueous extract of A. fructus and at doses of ≥ 0.5 mg/kg/day AAs. For both genders, the no-observed-adverseeffect level (NOAEL) for A. fructus based on this subchronic study in rats was considered to be 21.3 mg/kg/d. Copyright
AB - The subchronic toxicity of Aristolochiae fructus containing aristolochic acids (AAs), a natural component in the Aristolochiaceae family, was investigated. The A. fructus was daily administered by gavage to male and female rats for 90 d at dose levels of 21.35, 213.5, and 2135 mg/kg (equivalent to 0.05, 0.5, and 5 mg/kg as AAs, respectively). During the test period, clinical signs, mortality, body weights, food and water consumption, hematology, serum biochemistry, organ weights, and histopathology were examined. Significant decreases in body weight gain were noted in the high-dose group receiving both the aqueous extract of A. fructus and AAs. Decreases in food consumption were noted beginning at 50 d and did not recover in the highdose group of aqueous extract of A. fructus and AAs. Irrespective of dose, water consumption was not affected. There was no mortality or adverse clinical signs, hematology, or serum biochemistry in the treatment groups versus control. Nephrotoxicity and hyperplasia of epithelial cells in the forestomach were observed in rats receiving the highest dose of aqueous extract of A. fructus and at doses of ≥ 0.5 mg/kg/day AAs. For both genders, the no-observed-adverseeffect level (NOAEL) for A. fructus based on this subchronic study in rats was considered to be 21.3 mg/kg/d. Copyright
UR - http://www.scopus.com/inward/record.url?scp=33750739226&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33750739226&partnerID=8YFLogxK
U2 - 10.1080/15287390600747965
DO - 10.1080/15287390600747965
M3 - Article
C2 - 17062506
AN - SCOPUS:33750739226
SN - 1528-7394
VL - 69
SP - 2157
EP - 2165
JO - Journal of Toxicology and Environmental Health - Part A: Current Issues
JF - Journal of Toxicology and Environmental Health - Part A: Current Issues
IS - 24
ER -